COMMUNIQUÉS West-GlobeNewswire

-
60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases
08/05/2024 -
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
08/05/2024 -
Treos Bio to Present New Clinical Data on Off-the-Shelf Peptide Immunotherapy for Colorectal Cancer at 2024 ASCO Annual Meeting
08/05/2024 -
IntelGenx Announces Voting Results on Election of Directors
08/05/2024 -
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
08/05/2024 -
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
08/05/2024 -
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
08/05/2024 -
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
08/05/2024 -
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
08/05/2024 -
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
08/05/2024 -
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
08/05/2024 -
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
08/05/2024 -
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
08/05/2024 -
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
08/05/2024 -
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
08/05/2024 -
Immunocore reports first quarter financial results and provides a business update
08/05/2024 -
Body & Brain Yoga Tai Chi to Provide Online Wellness Sessions for AARP Audience
08/05/2024 -
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
08/05/2024 -
ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator
08/05/2024
Pages